Handa Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development of niche drug. The company’s overall business strategy comprises of utilizing our Taiwan headquarter as our global R&D center and establishing our presence in the world’s two largest pharmaceutical markets (the US and China).

Handa Pharma integrates its own pharmaceutical development platform with patent analysis, medicine and pharmaceuticals regulatory, and market planning to focus on the development of high barrier/patentable niche products, including：

• 505(b)(2) New drug development
• High barrier/patentable generics development

  In-House Development (Fully Ownership)
  Co-Development (Share Risk, Cost and Profit)
  Out-Licensing (Upfront, Milestones and Profit Sharing)

Handa’s mission is to meet “unmet medical needs” by its own pharmaceutical development platform.

We believes science and integrity will enable it to create the best value for its stakeholders including patients, medical practitioners, payers, employees, and investors.

The Vision of Handa is to create better drugs to improve patients’ quality of life.